share buyback and new apptment

Arana Announces On-Market Share Buy-back
•
Buy-back of up to 10% of ordinary shares
•
Buy-back to commence on 27 October 2008, for 12-month period
Biotechnology company Arana Therapeutics Limited (ASX: AAH) today announced that it intends to conduct an on-market buy-back of up to 10% of the company’s ordinary shares.
The buy-back is expected to commence on 27 October 2008, and will continue for a 12-month period. All shares purchased under the on-market buy-back will be cancelled by the company...


(at the moment ~234million shares exercised
market cap ~$195million
----------------------

Arana Strengthens Board with New Appointment
Biotechnology company Arana Therapeutics Limited (ASX: AAH) today announced the appointment of Gordon Black as a non-independent non-executive director of the company.
Mr Black is managing director of Biofusion Capital (a significant shareholder of Arana), a specialist life sciences venture capital fund and an early stage investor in EvoGenix Limited. He is associated with Arana’s major shareholder Yap Lim Sen.
Robin Beaumont, Chairman of Arana said “Gordon Black brings a wealth of experience to the Arana board, in particular through his connections in the biotechnology industry...”